Fast-paced Momentum Stock Puma Biotech (PBYI) Is Still Trading at a Bargain

Group 1 - Momentum investing focuses on "buying high and selling higher" rather than traditional "buying low and selling high" strategies [1] - Fast-moving trending stocks can lose momentum if their future growth does not justify their high valuations, leading to potential downside risks for investors [2] - A safer investment strategy involves identifying bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score [3] Group 2 - Puma Biotech (PBYI) is highlighted as a strong candidate for momentum investing, with a recent price increase of 3.6% over the past four weeks [4] - PBYI has shown a significant price gain of 13.2% over the past 12 weeks, indicating its potential for sustained positive returns [5] - The stock has a beta of 1.29, suggesting it moves 29% more than the market, indicating fast-paced momentum [5] Group 3 - PBYI has a Momentum Score of B, suggesting it is an opportune time to invest in the stock to capitalize on its momentum [6] - The stock has received a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which typically attract more investor interest [7] - PBYI is trading at a Price-to-Sales ratio of 0.71, indicating it is undervalued at 71 cents for each dollar of sales, providing room for growth [7] Group 4 - In addition to PBYI, there are other stocks that meet the criteria for fast-paced momentum at a bargain, which investors may consider [8] - Zacks offers over 45 Premium Screens tailored to different investing styles, aiding in the identification of potential winning stocks [9]